Stem Cell Technology: Current Applications and Future Directions

Table of Contents

• Stem Cell Technology: Current Applications and Future Directions

Chapter- 1: SUMMARY

• SUMMARY TABLE U.S. MARKET FOR STEM CELLS IN REGENERATIVE MEDICINE REVENUE, THROUGH 2012 ($ MILLIONS)
• SUMMARY FIGURE U.S. MARKET FOR STEM CELLS IN REGENERATIVE MEDICINE REVENUE, 2005-2012 ($ MILLIONS)

Chapter- 2: OVERVIEW

• HISTORICAL REVIEW OF STEM CELL BIOLOGY
• HISTORY OF STEM CELL BIOLOGY
• EARLY OBSERVATION AND CLASSIFICATIONS
• STEM CELL CLASSIFICATION
• Derivation of Human Tissue Types during Development from Embryonic Stem Cells
  • TABLE 1 DERIVATION OF HUMAN TISSUE TYPES DURING DEVELOPMENT
  • FIGURE 1 FLOW DIAGRAM OF HUMAN DEVELOPMENT PROCESS
• Derivation of Human Tissue Following Maturation from Adult Stem Cells
• STEM CELL CONCEPTS IN HEALTH CARE
• INITIAL STEM CELL ISOLATION AND CHARACTERIZATION
• Initial Stem Cell Isolation ...(Continued)
• EARLY CELL-BASED THERAPEUTICS
• Xeno Transplants
• Blood Transfusions and Bone Marrow Transplantation
• AREAS OF HEALTH CARE NEED AND STEM CELLS
• DISEASE- AND DEGENERATION-RELATED HEALTH CARE NEED
• Disease- and Degeneration-...(Continued)
• ORGAN TRANSPLANTATION-RELATED HEALTH CARE NEED
• CANCER- AND GENETIC DISORDER-RELATED HEALTH CARE NEED
• INFECTIOUS DISEASE-RELATED HEALTH CARE NEED
• HEALTH CARE NEED AND COSTS
• Health Care Need and Costs (Continued)
• CURRENT STATE OF REGENERATIVE MEDICINE
• STEM CELL CLASSIFICATION BASED ON SOURCE
• Embryonic Stem Cells
• Adult (and Progenitor) Stem Cells
• Adult (and Progenitor) ...(Continued)
• STEM CELL CLASSIFICATION BASED ON DIFFERENTIATION POTENTIAL
• Pluripotent Stem Cell Differentiation Potential
• Multipotent Stem Cell Differentiation Potential
• Unipotent Stem Cell Differentiation Potential
  • TABLE 2 STEM CELL CLASSIFICATION BASED ON DIFFERENTIATION POTENTIAL
• DYNAMICALLY EVOLVING AREAS IN STEM CELL BIOLOGY
• CLONAL STEM CELLS LINES IN NONHUMAN PRIMATES
• EMBRYONIC STEM CELL LINES DERIVED FROM INNER CELL MASS OF VIABLE EMBRYOS
• STEM CELLS FROM NEONATAL FLUID
• ADULT STEM SOURCING/NICHES
• Adult Stem Sourcing/Niches (Continued)
  • TABLE 3 ADULT STEM CELL TYPES AND POTENTIAL TISSUE SOURCES
• DISEASE-SPECIFIC EMBRYONIC STEM CELL LINES
• ADULT STEM CELL REPROGRAMMING
• PERSONALIZED HEALTH CARE
• CELL-BASED THERAPEUTICS
• Using Embryonic-derived Stem Cells
• Using Adult/Progenitor-derived Stem Cells
• ENGINEERED TISSUE FOR TRANSPLANTATION
• Using Embryonic-derived Stem Cells
• Using Adult Stem Cells (and Progenitor Cells)
• THERAPEUTIC STEM CELL BANKING
• STEM-CELL-BASED BIOMEDICAL RESEARCH
• MARKETS FOR STEM-CELL-BASED CELLULAR THERAPEUTICS
• HEALTH CARE NEED AND THE APPLICATION OF STEM CELLS
• Cardiovascular System-related Clinical Stem Cell Applications
• Nervous System-related Clinical Stem Cell Applications
• Skeletal/Muscular System-related Clinical Stem Cell Applications
• Whole Organ (Tissue) System-related Clinical Stem Cell Applications
• Stem-cell-related Cancer and Clinical Applications
• Infectious Disease/Cancer (General) and Clinical Applications
• GOVERNMENT REGULATIONS AND THE USE OF STEM CELLS IN RESEARCH AND THERAPEUTIC APPLICATIONS
• GOVERNMENT REGULATION OF THE APPLICATION OF STEM-CELL-BASED THERAPEUTICS
• Government Regulation of...(Continued)
• GOVERNMENT REGULATION OF THE APPLICATION OF STEM-CELL-BASED RESEARCH
  • TABLE 4 THE NATIONAL INSTITUTES OF HEALTH STEM CELL RESEARCH FUNDING, 2004-2009 ($ MILLIONS)
  • TABLE 4 (CONTINUED)
  • FIGURE 2 THE NATIONAL INSTITUTES OF HEALTH HUMAN STEM CELL RESEARCH FUNDING, 2004-2009 ($ MILLIONS)
  • TABLE 5 THE NATIONAL INSTITUTES OF HEALTH HUMAN EMBRYONIC STEM CELL REGISTRY
  • TABLE 5 (CONTINUED)
  • TABLE 6 STATES FUNDING STEM-CELL-RELATED RESEARCH
• FUTURE IMPACT OF STEM CELLS ON UNMET HEALTH CARE NEED
• FUTURE IMPACT OF STEM ...(CONTINUED)
• STEM CELL TECHNOLOGY IN THE REGENERATIVE MEDICINE MARKET
  • TABLE 7 PROJECTED U.S. GROWTH TREND FOR STEM CELLS IN REGENERATIVE MEDICINE, THROUGH 2012 ($ MILLIONS)
  • FIGURE 3 PROJECTED U.S. GROWTH TREND FOR STEM CELLS IN REGENERATIVE MEDICINE, 2005-2012 ($ MILLIONS)
• INTRODUCTION TO STEM CELLS TECHNOLOGY IN REGENERATIVE MEDICINE MARKET
• STEM CELLS IN CELLULAR THERAPEUTICS
• Stem Cells in Cellular Therapeutics (Continued)
• Stem Cells in Cellular Therapeutics (Continued)
  • FIGURE 4 FLOW DIAGRAM OF PROCESS USING STEM CELLS IN CELLULAR THERAPEUTICS
• Stem Cells in Cellular Therapeutics (Continued)
  • TABLE 8 PROJECTED U.S. GROWTH TREND FOR STEM CELLS IN CELL-BASED THERAPEUTICS FOR HUMAN ADULT AND EMBRYONIC STEM CELLS, THROUGH 2012 ($ MILLIONS)
  • FIGURE 5 PROJECTED U.S. GROWTH TREND FOR STEM CELLS IN CELL-BASED THERAPEUTICS FOR HUMAN ADULT AND EMBRYONIC STEM CELLS, 2005-2012 ($ MILLIONS)
• Stem Cells in Cellular Therapeutics towards Engineering Tissue in Vitro for Transplantation
• Stem Cells in Cellular Therapeutics ...(Continued)
• Stem Cells in Cellular Therapeutics ...(Continued)
  • FIGURE 6 FLOW DIAGRAM OF PROCESS USING STEM CELLS IN ENGINEERING TISSUE FOR TRANSPLANTATION
• THERAPEUTIC STEM CELL BANKING
  • FIGURE 7 FLOW DIAGRAM FOR PROCESS OF THERAPEUTIC BANKING OF STEM CELLS
• Therapeutic Stem Cell Banking (Continued)
  • TABLE 9 PROJECTED U.S. GROWTH TREND FOR THERAPEUTIC STEM CELL BANKING, THROUGH 2012 ($ MILLIONS)
  • FIGURE 8 PROJECTED U.S. GROWTH TREND FOR THERAPEUTIC STEM CELL BANKING, 2005-2012 ($ MILLIONS)
• INTRODUCTION TO STEM CELLS TECHNOLOGY IN THERAPEUTIC-RELATED RESEARCH
• STEM CELL TECHNOLOGY IN CELL-BASED ASSAYS AND DIAGNOSTIC RESEARCH APPLICATIONS
  • TABLE 10 PROJECTED U.S. GROWTH TREND FOR STEM-CELL-RELATED THERAPEUTIC RESEARCH ($ MILLIONS)
  • FIGURE 9 PROJECTED U.S. GROWTH TREND FOR STEM-CELL-RELATED THERAPEUTIC RESEARCH, 2005-2012 ($ MILLIONS)
• THERAPEUTIC STEM-CELL-RELATED RESEARCH SUPPORT
  • TABLE 11 PROJECTED U.S. GROWTH TREND FOR STEM-CELL-RELATED CELL-BASED ASSAYS/DIAGNOSTICS THERAPEUTIC RESEARCH BY SEGMENT, THROUGH 2012 ($ MILLIONS)
  • FIGURE 10 PROJECTED U.S. GROWTH TREND FOR STEM-CELL-RELATED CELL-BASED ASSAYS/DIAGNOSTICS THERAPEUTIC RESEARCH BY SEGMENT, 2005-2012 ($ MILLIONS)
• FACTORS DRIVING AND INHIBITING APPLICATION OF STEM CELL TECHNOLOGY
• Factors Driving and Inhibiting ...(Continued)
• Factors Driving and Inhibiting ...(Continued)
• Factors Driving and Inhibiting ...(Continued)
  • TABLE 12 FACTORS DRIVING AND INHIBITING THE APPLICATION OF STEM-CELL-BASED THERAPEUTICS

Chapter- 3: MARKETS BY TYPES OF APPLICATIONS

• INTRODUCTION TO STEM-CELL-THERAPEUTIC-BASED APPLICATIONS
• STEM CELL APPLICATIONS: REGENERATIVE MEDICINE
• Stem Cell Applications Specifically by Tissue Type
• Stem Cell Applications Specifically by Organ System Type
• Stem Cell Applications in Infectious Disease, Genetic Disorders, and Cancer-related
  • TABLE 13 STEM CELL TECHNOLOGY APPLICATIONS IN REGENERATIVE MEDICINE
• STEM CELL APPLICATIONS IN RESEARCH AND DEVELOPMENT
• Stem Cell Applications in Academic Research
• Stem Cell Applications in Biotechnology and Medical Device Research
• Stem Cells in Pharmaceutical Research
  • TABLE 14 STEM CELL TECHNOLOGY AREAS OF APPLICATION WITHIN THE LIFE SCIENCES

Chapter- 4: STEM CELL TECHNOLOGY AND DEVELOPMENT

• STEM CELL PRODUCTION
• STEM CELL ACQUISITION
• CHARACTERIZATION AND EXPANSION
• MAINTENANCE AND STORAGE
  • FIGURE 11 FLOW DIAGRAM FOR PROCESS OF STEM CELL PRODUCTION
• STEM CELL PRODUCTION ECONOMICS
• STEM CELL PRODUCTION ECONOMICS (CONTINUED)
• NOVEL STEM CELL PRODUCTION DEVELOPMENTS
• ISOLATION AND ENGINEERING
• NOVEL DEVELOPMENTS IN THE PRODUCTION OF ADULT STEM CELLS
• NOVEL DEVELOPMENTS IN THE PRODUCTION OF EMBRYONIC STEM CELLS
• Novel Developments in the Production ...(Continued)
• LEADERS IN STEM CELL RESEARCH DEVELOPMENT
• ACADEMIC RESEARCH AND DEVELOPMENT LEADERS
• Academic Stem Cell Research and Development Scientists
• George Q. Daley, MD, Ph.D.
• Kevin Eggan, Ph.D.
• Doug Melton, Ph.D.
• Amy Wagers, Ph.D.
• Robert Langer, Sc.D.
• Irving Weissman, MD
• Stuart Orkin, MD
• Joseph Vacanti, MD
• Kenneth Chien, MD, Ph.D.
• Rudolf Jaenisch, MD
• Daniel Tenen, MD
• Konrad Hochedlinger, Ph.D.
• Paul Matsudaira, Ph.D.
• Anthony Atala, MD
• Elaine Fuchs, Ph.D.
• David J. Mooney, Ph.D.
• James A. Thomson, Ph.D.
• Shinya Yamanaka, MD, Ph.D.
• Kacey G. Marra, Ph.D.
• Gordon Keller, Ph.D.
• Johnny Huard, Ph.D.
• Hans Keirstead, Ph.D.
• Shoukhrat Mitalipov, Ph.D.
• Gordon Keller, Ph.D.
  • TABLE 15 HIGHLIGHTED STEM CELL RESEARCH PUBLICATIONS, 2005-2008
  • TABLE 15 (CONTINUED)
  • TABLE 15 (CONTINUED)
• INDUSTRY RESEARCH AND DEVELOPMENT LEADERS
• TECHNOLOGY PATENT ANALYSIS
• GENERAL TRENDS
  • TABLE 16 STEM CELL PATENT TRENDS, 2000-2008
  • FIGURE 12 STEM CELL PATENT TRENDS, 2000-2008
• TRENDS BY COUNTRY
  • TABLE 17 STEM CELL PATENT COUNTRY CODES, 2000-2008
  • TABLE 18 STEM CELL PATENT TRENDS BY COUNTRY, 2000-2008
  • TABLE 19 STEM CELL PATENT TRENDS BY COUNTRY OF PATENTS, 2000-2008 (%)
  • FIGURE 13 STEM CELL PATENT TRENDS BY COUNTRY % OF PATENTS, 2000-2008 (%)
• TRENDS BY COMPANIES
  • TABLE 20 STEM CELL PATENT TRENDS BY COMPANIES ASSIGNED TWO OR MORE PATENTS, 2000-2008

Chapter- 5: STEM CELL INDUSTRY STRUCTURE

• DRIVING FORCES IN STEM-CELL-BASED INDUSTRIES
• DRIVING FORCES IN THE HEALTH CARE MARKET
• BIOTECHNOLOGY
• PHARMACEUTICAL
• COMPETITIVE ADVANTAGES IN STEM-CELL-BASED INDUSTRIES
• TECHNOLOGY DEVELOPMENT AND UTILIZATION
• COST OF NEW PRODUCT DEVELOPMENT, MANUFACTURING, AND LAUNCH
• Cost of New Product Development, ... (Continued)
• MARKET POSITIONING AND CAPTURE
• Market Positioning and Capture (Continued)
• Market Positioning and Capture (Continued)
• IMPORTANT SHIFTS IN INDUSTRY
• CONTINUOUSLY EVOLVING TECHNOLOGICAL BASE
• Continuously Evolving Technological Base (Continued)
• EFFECTS OF FLUCTUATIONS IN FEDERAL GOVERNMENT AND FOOD AND DRUG ADMINISTRATION REGULATORY FACTORS
  • TABLE 21 RESTRICTIONS ON STEM CELL RESEARCH BY STATE
  • TABLE 21 (CONTINUED)
  • TABLE 21 (CONTINUED)
  • TABLE 21 (CONTINUED)
  • TABLE 21 (CONTINUED)
  • TABLE 21 (CONTINUED)
  • TABLE 21 (CONTINUED)
• Food and Drug Administration Approval Requirements for Implementation of Stem-cell-based Therapeutics
• STAGE OF STEM CELL LIFE CYCLE
  • TABLE 22 TOTAL NUMBER OF STEM CELL CLINICAL TRIALS, 2000-2008
  • FIGURE 14 TOTAL NUMBER OF STEM CELL CLINICAL TRIALS, 2000-2008
  • TABLE 23 TOTAL NUMBER OF STEM CELL CLINICAL TRIALS FUNDED BY INDUSTRY, 2000-2008
  • FIGURE 15 TOTAL NUMBER OF STEM CELL CLINICAL TRIALS FUNDED BY INDUSTRY, 2000-2008
  • TABLE 24 STEM CELL CLINICAL TRIALS RELATED TO CANCER (PERIPHERAL BLOOD/BONE MARROW TRANSPLANTATION), 2000-2008 (%)
  • FIGURE 16 STEM CELL CLINICAL TRIALS RELATED TO CANCER (PERIPHERAL BLOOD/BONE MARROW TRANSPLANTATION), 2000-2008 (%)
• IMPACT ON EXISTING HEALTH CARE MARKET MAY BE SIGNIFICANT
• MAJOR STEM CELL COMPANIES
• MAJOR STEM CELL MARKETS
• Stem Cell Market Segmentation
• Stem Cell Market Forces
• Stem Cell Market Forces (Continued)
• GENERAL STEM CELL TECHNOLOGY ISSUES
• STEM CELL TECHNOLOGY ISSUES BY TECHNOLOGY TYPE
• Embryonic Stem Cells
• Adult Stem Cells
• STEM CELL COMPANIES PERCENT MARKET SHARE
• Stem Cell Companies Percent Market Share (Continued)
  • TABLE 25 MARKET SHARE OF STEM CELL THERAPEUTICS (AND BANKING) COMPANIES, 2005-2007 (%)

Chapter- 6: COMPANY PROFILES

• AASTROM BIOSCIENCES, INC.
  • TABLE 26 AASTROM BIOSCIENCES, INC. STEM CELL CLINICAL TRIALS
  • TABLE 26 (CONTINUED)
  • TABLE 27 AASTROM BIOSCIENCES, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• ALDAGEN, INC
  • TABLE 28 ALDAGEN, INC. STEM CELL CLINICAL TRIALS
  • TABLE 29 ALDAGEN, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• ADVANCED CELL TECHNOLOGY, INC.
  • TABLE 30 ADVANCED CELL TECHNOLOGY, INC. STEM CELL CLINICAL TRIALS
  • TABLE 31 ADVANCED CELL TECHNOLOGY, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
  • TABLE 31 (CONTINUED)
• ARTERIOCYTE, INC.
  • TABLE 32 ARTERIOCYTE, INC. STEM CELL CLINICAL TRIALS
• ATHERSYS, INC.
• BD BIOSCIENCES
• BIO-MATRIX SCIENTIFIC GROUP, INC.
• BIOE
  • TABLE 33 BIOE STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• BIOHEART, INC.
  • TABLE 34 BIOHEART, INC. STEM CELL CLINICAL TRIALS
  • TABLE 35 BIOHEART, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• CELGENE CORP.
• CELLERANT THERAPEUTICS, INC.
  • TABLE 36 CELLERANT THERAPEUTICS, INC. STEM CELL CLINICAL TRIALS
  • TABLE 37 CELLERANT THERAPEUTICS, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• CELLULAR DYNAMICS INTERNATIONAL, INC.
• COGNATE BIOSERVICES, INC.
  • TABLE 38 COGNATE BIOSERVICES, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• CRYO-CELL INTERNATIONAL, INC.
• CYTOMATRIX, LLC
  • TABLE 39 CYTOMATRIX, LLC STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• CYTORI THERAPEUTICS, INC.
  • TABLE 40 CYTORI THERAPEUTICS, INC. STEM CELL CLINICAL TRIALS
  • TABLE 41 CYTORI THERAPEUTICS, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
  • TABLE 41 (CONTINUED)
• ENDGENITOR TECHNOLOGIES, INC.
• FORTICELL BIOSCIENCE, INC.
  • TABLE 42 FORTICELL BIOSCIENCE, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• GERON CORP
  • TABLE 43 GERON CORP STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• HEALTHEUNIVERSE, INC.
  • TABLE 44 HEALTHEUNIVERSE, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• INTERNATIONAL STEM CELL CORPORATION
• INVITROGEN CORPORATION
• MATTEK CORPORATION
  • TABLE 45 MATTEK CORP STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• MEDISTEM LABORATORIES, INC.
  • TABLE 46 MEDISTEM LABORATORIES, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• MEDRA, INC.
• MILLIPORE
• MORPHOGENESIS, INC.
  • TABLE 47 MORPHOGENESIS, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• MG BIOTHERAPEUTICS, LLC
• MORAGA BIOTECHNOLOGY CORPORATION
• NEOSTEM, INC.
  • TABLE 48 NEOSTEM, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• NEURALSTEM, INC.
  • TABLE 49 NEURALSTEM, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• NEUROGENERATION
• NEURONYX, INC.
  • TABLE 50 NEURONYX, INC. STEM CELL CLINICAL TRIALS
  • TABLE 51 NEURONYX, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• NUTECH MEDICAL, INC.
• NOVOCELL, INC.
  • TABLE 52 NOVOCELL, INC STEM CELL CLINICAL TRIALS
  • TABLE 53 NOVOCELL, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• OPEXA THERAPEUTICS, INC.
  • TABLE 54 OPEXA THERAPEUTICS, INC. STEM CELL CLINICAL TRIALS
• ORGANOGENESIS, INC.
  • TABLE 55 ORGANOGENESIS, INC. STEM CELL CLINICAL TRIALS
  • TABLE 56 ORGANOGENESIS, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• OSIRIS THERAPEUTICS, INC.
  • TABLE 57 OSIRIS THERAPEUTICS, INC. STEM CELL CLINICAL TRIALS
  • TABLE 57 (CONTINUED)
  • TABLE 58 OSIRIS THERAPEUTICS, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• PHARMASTEM THERAPEUTICS, INC.
  • TABLE 59 PHARMASTEM THERAPEUTICS, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• PRIMEGEN BIOTECH, LLC
• PROGENITOR CELL THERAPY, LLC
• REGENETECH, INC
  • TABLE 60 REGENETECH, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• SANERON CCEL THERAPEUTICS, INC.
• STEM CELL INNOVATIONS
  • TABLE 61 STEM CELL INNOVATIONS STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• STEM CELLS, INC.
  • TABLE 62 STEM CELLS, INC. STEM CELL CLINICAL TRIALS
  • TABLE 63 STEM CELLS, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• STEM CELL THERAPY INTERNATIONAL CORP.
• STEMCELL PHARMA, INC.
• STEMCYTE, INC.
• STEMEDICA CELL TECHNOLOGIES, INC.
• TENGION, INC.
  • TABLE 64 TENGION, INC. STEM CELL CLINICAL TRIALS
• THERADIGM, INC.
  • TABLE 65 THERADIGM, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• THERMOGENESIS CORP.
• VESTA THERAPEUTICS, INC.
  • TABLE 66 VESTA THERAPEUTICS, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• VIACELL, INC.
  • TABLE 67 VIACELL, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• VIACORD
• VISTAGEN THERAPEUTICS, INC.
  • TABLE 68 VISTAGEN THERAPEUTICS, INC. STEM CELL CLINICAL TRIALS
  • TABLE 69 VISTAGEN THERAPEUTICS, INC. STEM CELL PATENTS ISSUED OR EXCLUSIVELY LICENSED
• VITRO DIAGNOSTICS, INC.
• VITRO DIAGNOSTICS, INC. (CONTINUED)

Chapter- 7: INTERNATIONAL ASPECTS OF REGENERATIVE MEDICINE/STEM CELL MARKET

• INTERNATIONAL ASPECTS OF...
  • TABLE 70 LEADING GLOBAL REGENERATIVE MEDICINE/STEM CELL COMPANIES

Chapter- 8: REFERENCES

• REFERENCES
• REFERENCES (CONTINUED)
• REFERENCES (CONTINUED)
• REFERENCES (CONTINUED)
• REFERENCES (CONTINUED)
• REFERENCES (CONTINUED)
• REFERENCES (CONTINUED)
• REFERENCES (CONTINUED)
• REFERENCES (CONTINUED)
• REFERENCES (CONTINUED)

Chapter- 9: APPENDIX A ABBREVIATIONS

• APPENDIX A - ABBREVIATIONS

Chapter- 10: APPENDIX B GLOSSARY

• APPENDIX B - GLOSSARY
• APPENDIX B - GLOSSARY (CONTINUED)
• APPENDIX B - GLOSSARY (CONTINUED)

Chapter- 11: APPENDIX C STEM CELL PATENTS, 2000-2008

• TABLE 71 STEM CELL PATENTS BETWEEN THE YEARS 2000 AND 2008
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)
• TABLE 71 (CONTINUED)